Encouraging results from phase 1/2 COVID-19 vaccine trials

Lancet. 2020 Aug 15;396(10249):448-449. doi: 10.1016/S0140-6736(20)31611-1. Epub 2020 Jul 20.

Authors

Naor Bar-Zeev¹, William J Moss²

Affiliations

¹ International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA. Electronic address: nbarzee1@jhu.edu.
² International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Vaccines
Coronavirus Infections / epidemiology*
Coronavirus Infections / prevention & control
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Single-Blind Method
Viral Vaccines

Substances

COVID-19 Vaccines
Viral Vaccines